Risk factors for cervical presence of human papillomavirus DNA among women at risk for HIV infection

Epidemiology and Infection

Volumn 121, Issue 1, 1998, Pages 173-177

  Rezza, G ^a   Giuliani, M ^a   Serraino, D ^b   Branca, M ^a   Benedetto, A ^c   Garbuglia, A ^d   Ippolito, G ^d   Franceschi, S ^b  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^c SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^d NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; VIRUS DNA;

ADOLESCENT; ADULT; AGE; ARTICLE; CIGARETTE SMOKING; EDUCATION; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ITALY; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; POLYMERASE CHAIN REACTION; REGRESSION ANALYSIS; RISK FACTOR; SEXUALITY; UTERINE CERVIX; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

DNA, VIRAL; FEMALE; HIV INFECTIONS; HUMANS; ITALY; LOGISTIC MODELS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL DISEASES;

EID: 0031719574     PISSN: 09502688     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0950268898008954     Document Type: Article

References (22)

1. Munoz N, Bosch FX de Sanjosé, Tafur L, et al. The causal link between human papilloma virus and invasive cervical cancer: a population-based case-control study in Colombia and Spain. Int J Cancer 1992; 52: 743-9.
2. Bosch FX de Sanjosé, Munoz N, Izarzugaza I, et al. Risk factors for cervical cancer in Colombia and Spain. Int J Cancer 1992; 52: 750-8.
3. Ho GYF, Burk RD, Fleming I, Klein RS. Risk of genital human papillomavirus in women with human immunodeficiency virus-induced immunosuppression. Int J Cancer 1994; 53: 788-92.
4. Franco EL, Villa LL, Ruiz A, Costa MC. Transmission of cervical human papillomavirus infection by sexual activity: differences between low and high oncogenic risk group. J Infect Dis 1995; 172: 756-63.
5. Rezza G, Giuliani M, Branca M, et al. Determinants of squamous intraepithelial lesions (SIL) on Pap smear: the role of HPV infection and of HIV-1 induced immunosuppression. Eur J Epidemiol. In press.
6. Stevenson M, Meier C, Mann AM, Chapman N, Wasiak A. Envelope glycoprotein of HIV induces interference and citolysis resistance in CD4 cells: mechanism for persistence in AIDS. Cell 1988; 53: 483-96.
7. Manos MM, Ting Y, Wright DK, Lewis AJ, Broker TR, Wolinsky SM. The use of polymerase-chain-reaction amlification for the detection of genital human papillomaviruses. Cancer Cells 1989; 7: 209-14.
8. Bernard G. Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction (PCR) amplification restriction fragment length polymorphisms, nucleotide sequence, and phylogenetics algorithms. J Infect Dis 1994; 170: 1077-85.
9. Cappiello G, Garbuglia AR, Salvi R, et al. HIV infection increases the risk of squamous intra-epithelial lesions in women with HPV infection: an analysis of HPV genotypes. Int J Cancer, 1997; 72: 982-6.
10. Herrington SC. Human papillomavirus and cervical neoplasia. Classification, virology, pathology and epidemiology. J Clin Pathol 1994; 47: 1066-72.
11. Breslow NE, Day NE. Statistical methods in cancer research, vol 1. The analysis of case-control studies. IARC Sci Publ No. 32, Lyon: IARC, 1980.
12. Feingold AR, Vermund SH, Burk RD, et al. Cervical cytologic abnormalities and papillomavirus in women infected with human immunodeficiency virus. J Acquir Immune Defic Syndr 1990; 3: 896-903.
13. Laga M, Icenogle JP, Marsella R, et al. Genital papillomavirus infection and cervical dysplasia - opportunistic complications of HIV infection. Int J Cancer 1992; 50: 45-8.
14. ter Meulen J, Eberhardt HC, Luande J, et al. Human papillomavirus (HPV) infection, HIV infection and cervical cancer in Tanzania, East Africa. Int J Cancer 1992; 51: 515-21.
15. Sun X-W, Ellerbrock RV, Lungu O, et al. Human papillomavirus infection in human immunodeficiency virus-seropositive women. Obstet Gynecol 1995; 85: 680-6.
16. Vernon SD, Reeves WC, Clancy KA, et al. A longitudinal study of human papillomavirus DNA detection in human immunodeficiency virus type 1-seropositive and -seronegative women. J Infect Dis 1994; 169: 1108-12.
17. Saragoni A, Medri L, Bacci F, et al. Value of the in situ hybridization technique in the diagnosis of human papillomavirus infections of the uterine cervix: correlations between the human papilloma virus type and the morphological features. Pathologica 1992; 84: 57-66.
18. Serraino D, Franceschi S, Vaccher E, et al. Risk factors for human immunodeficiency virus infection in 581 intravenous drug users, Northeast Italy, 1984-1988. Int J Epidemiol 1991; 20: 264-70.
19. Serraino D, Franceschi S, Vaccher E, et al. Condom use and sexual habits of heterosexual intravenous drug users in Northern Italy. Eur J Epidemiol 1992; 8: 723-9.
20. Serraino D, Napoli PA, Zaccarelli M, et al. High frequency of invasive cervical cancer among female injecting drug users with AIDS in Italy. AIDS 1996; 10: 1041-2.
21. Johnson JC, Burnett AF, Willet GD, et al. High frequency of latent and clinical human papillomavirus cervical infections in immunocompromised human immunodeficiency virus-infected women. Obstet Gynecol 192; 79: 321-7.
22. Melbye M, Smith E, Wohlfahrt J, et al. Anal and cervical abnormality in women - prediction by human papillomavirus tests. Int J Cancer 1996; 68: 559-64.